225 related articles for article (PubMed ID: 8747752)
1. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction.
Herman BH; Vocci F; Bridge P
Neuropsychopharmacology; 1995 Dec; 13(4):269-93. PubMed ID: 8747752
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance.
Pasternak GW; Kolesnikov YA; Babey AM
Neuropsychopharmacology; 1995 Dec; 13(4):309-13. PubMed ID: 8747755
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.
Elliott K; Kest B; Man A; Kao B; Inturrisi CE
Neuropsychopharmacology; 1995 Dec; 13(4):347-56. PubMed ID: 8747759
[TBL] [Abstract][Full Text] [Related]
4. Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence.
Trujillo KA
Neuropsychopharmacology; 1995 Dec; 13(4):301-7. PubMed ID: 8747754
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
Zhu H; Barr GA
Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress.
Abdel-Zaher AO; Abdel-Rahman MS; Elwasei FM
Neurotoxicology; 2011 Dec; 32(6):725-33. PubMed ID: 21855572
[TBL] [Abstract][Full Text] [Related]
7. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
Klamer D; Zhang J; Engel JA; Svensson L
Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
[TBL] [Abstract][Full Text] [Related]
8. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal.
Rasmussen K
Neuropsychopharmacology; 1995 Dec; 13(4):295-300. PubMed ID: 8747753
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
Vaupel DB; Kimes AS; London ED
Neuropsychopharmacology; 1995 Dec; 13(4):315-22. PubMed ID: 8747756
[TBL] [Abstract][Full Text] [Related]
10. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat.
Shim I; Kim HT; Kim YH; Chun BG; Hahm DH; Lee EH; Kim SE; Lee HJ
Eur J Pharmacol; 2002 May; 443(1-3):119-24. PubMed ID: 12044801
[TBL] [Abstract][Full Text] [Related]
12. [Blockade of opioid tolerance and dependence by NMDA receptor antagonist].
Zang MW; Liu JS
Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):207-13. PubMed ID: 12532781
[TBL] [Abstract][Full Text] [Related]
13. Bed nucleus of the stria terminalis N-methyl-D-aspartate receptors and nitric oxide modulate the baroreflex cardiac component in unanesthetized rats.
Alves FH; Crestani CC; Resstel LB; Correa FM
J Neurosci Res; 2009 May; 87(7):1703-11. PubMed ID: 19156861
[TBL] [Abstract][Full Text] [Related]
14. [NMDA-receptor antagonists: new pharmacological agents to control the subjective and motivational effects of narcotics].
Bespalov AIu; Zvartau EE
Vestn Ross Akad Med Nauk; 1998; (11):24-9. PubMed ID: 9889701
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant effect of dextrometrophan on pentylenetetrazole-induced seizures in mice: Involvement of nitric oxide and N-methyl-d-aspartate receptors.
Mohseni G; Ostadhadi S; Akbarian R; Chamanara M; Norouzi-Javidan A; Dehpour AR
Epilepsy Behav; 2016 Dec; 65():49-55. PubMed ID: 27875784
[TBL] [Abstract][Full Text] [Related]
16. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
17. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal.
Vaupel DB; Kimes AS; London ED
Psychopharmacology (Berl); 1995 Apr; 118(4):361-8. PubMed ID: 7568621
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus.
Nei K; Matsuyama S; Shuntoh H; Tanaka C
Brain Res; 1996 Jul; 728(1):105-10. PubMed ID: 8864303
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons.
Jewett DC; Butelman ER; Woods JH
Brain Res; 1996 Apr; 715(1-2):25-31. PubMed ID: 8739619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
